Thousands of people have partnered with an IVC filter lawyer or law firm to file lawsuits against C. R. Bard, claiming the company’s IVC filters cause injuries. Among other wrongful actions, negligence is the most serious accusation leveled against Bard, with evidence showing that the company likely knew about the risks of its Recovery filter before bringing it to market.
In 2016, plaintiffs with existing filter implants filed a lawsuit seeking class-action certification, which was transferred to MDL 2641. As of March 2019, there are 6,753 actions pending in the C. R. Bard MDL, with bellwether trials still underway.
In 2003, the United States Food and Drug Administration (FDA) approved the Cook Gunther Tulip IVC filter for permanent and temporary placement. Cook introduced the Celect vena cava filter in 2008, with FDA clearance following trials in other countries. After 27 actions in 11 districts alleged that Cook’s IVC filters caused injury, the U.S. Judicial Panel on Multidistrict Litigation consolidated them into MDL 2570 in the Southern District of Indiana.
When the number of actions continued to grow in 2015, pretrial proceedings moved forward, with the first bellwether cases selected in 2016. As of February 2019, there are 5,313 cases pending in the Cook IVC Filter MDL, alleging defective design, misrepresentation, and failure to warn doctors and patients.